FDA Drug Application (021852) for TACLONEX by LEO PHARMA AS

Back to FDA Applications sponsored by LEO PHARMA AS

Application Number021852
Product Number001
FormOINTMENT;TOPICAL
Dosage0.064%;0.005%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTACLONEX
Active IngredientBETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE

Active IngredientCount
List of drugs with Active Ingredient BETAMETHASONE DIPROPIONATE11
List of drugs with Active Ingredient CALCIPOTRIENE HYDRATE2


Back to FDA Applications sponsored by LEO PHARMA AS